NEW YORK, March 3, 2015 /PRNewswire/ -- Pomerantz LLP is
investigating claims on behalf of investors of Natus Medical, Inc.
("Natus" or the "Company") (NASDAQ: BABY). Such investors are
advised to contact Robert S.
Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext.
237.
The investigation concerns whether Natus and certain of its
officers and/or directors have violated Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934.
On March 3, 2015, the Company
reported material weakness due to aggregation of control
deficiencies resulting from a lack of timely risk assessment and
monitoring of internal controls. As a result, the Company
announced that it would be unable to file its annual report on Form
10-K in a timely manner.
On this news, shares of Natus fell $1.07 per share to $34.26, or more than 3.03%, on March 3, 2015.
The Pomerantz Firm, with offices in New York, Chicago, San
Diego and Florida, is
acknowledged as one of the premier firms in the areas of corporate,
securities, and antitrust class litigation. Founded by the late
Abraham L. Pomerantz, known as the
dean of the class action bar, the Pomerantz Firm pioneered the
field of securities class actions. Today, more than 70 years later,
the Pomerantz Firm continues in the tradition he established,
fighting for the rights of the victims of securities fraud,
breaches of fiduciary duty, and corporate misconduct. The Firm has
recovered numerous multimillion-dollar damages awards on behalf of
class members. See www.pomerantzlaw.com.
CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-natus-medical-inc--baby-300044807.html
SOURCE Pomerantz LLP